John Fowler, President & CEO of Supreme Pharmaceuticals (SL:CNSX, SPRWF:OTC), discusses the company’s future plans and their position in the medical marijuana sector.
Supreme is one of the most recently licensed companies in the medical marijuana sector in Canada. We operate one of the largest, most innovative greenhouse facilities in the world, which positions us to be one of the biggest companies in the Cannabis industry here in Canada.
In the medical marijuana market, We are looking to solve a value problem. We are looking to provide high-quality medical cannabis at an affordable and sustainable price point.
What sets us apart is our innovative greenhouse facility. It’s the first of its kind to be hybridized and modular, meaning it provides the best practices of indoor cultivation with the cost savings and sustainability of a greenhouse, we are focusing on scaling up the entire greenhouse. As the market develops, we’ll look to scale over the entire seven acres which is estimated to provide an output capacity of over 50,000 kilograms per year.
It was recently announced that the Liberal government, will be tabling legislation for recreational marijuana use in 2017. Supreme intends to use the intervening period to scale up the greenhouse and continue to develop our brand so we can hit the ground running in that market when it opens.
Supreme represents a compelling opportunity because it’s operating one of the largest, most innovative greenhouse facilities in the world, at a time when the medical market is maturing and expanding rapidly.
This is an exciting time to be in the marijuana industry. Globally, governments are looking to legalize medical and recreational marijuana, and it’s an opportunity to take advantage of a once-in-a-lifetime regulatory change.